Literature DB >> 2603888

Formulary management of biotechnological drugs.

E T Herfindal1.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2603888

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN： 0002-9289


× No keyword cloud information.
  4 in total

1.  The effects of acquisition cost and budget-based compensation on the attitudes of pharmacy directors toward the adoption of a cost-effective new drug.

Authors:  M Kolassa; M C Smith; B F Banahan; D D Garner; W F Shughart
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

2.  High technology drugs for cancer: the decision process for adding to a formulary.

Authors:  J L Glennie; D M Woloschuk; K W Hall
Journal:  Pharmacoeconomics       Date:  1993-12       Impact factor: 4.981

3.  Proactive review of biotechnological and other high-cost pharmaceuticals: a US approach.

Authors:  S A Iteen; S L Decker
Journal:  Pharmacoeconomics       Date:  1993-07       Impact factor: 4.981

4.  Therapeutic dilemmas. An approach to the management of expensive pharmaceutical advances.

Authors:  L Y Nishimura; R Shane
Journal:  Pharmacoeconomics       Date:  1994-12       Impact factor: 4.981
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.